Latest First Light Asset Management, LLC Stock Portfolio
$1.12Billion | No. of Holdings #35
First Light Asset Management, LLC Performance
2026 Q1-8.57%
YTD-8.57%
2025+24.43%
About First Light Asset Management, LLC and 13F Hedge Fund Stock Holdings
On 2026-05-15, the fund reported it's updated stock portfolio. In the 13F Holdings report, First Light Asset Management, LLC reported an equity portfolio of $1.1 Billions as of 31 Mar, 2026. <br><br> The top stock holdings of First Light Asset Management, LLC are AXGN, , NEO. The fund has invested 11.9% of it's portfolio in AXOGEN INC and 11% of portfolio in PALVELLA THERAPEUTICS INC. <br><br> The fund managers got completely rid off DISC MEDICINE INC, MADRIGAL PHARMACEUTICALS INC (MDGL) and DYNE THERAPEUTICS INC (DYN) stocks. They significantly reduced their stock positions in RHYTHM PHARMACEUTICALS INC (RYTM), VERA THERAPEUTICS INC (VERA) and ATRICURE INC (ATRC). First Light Asset Management, LLC opened new stock positions in TRISALUS LIFE SCIENCES INC, OMNICELL INC (OMCL) and GENEDX HOLDINGS CORP (SMFR). The fund showed a lot of confidence in some stocks as they added substantially to APOGEE THERAPEUTICS INC, NEUROPACE INC (NPCE) and SIMULATIONS PLUS INC (SLP).
First Light Asset Management, LLC Equity Portfolio Value
Last Reported on: 15 May, 2026
$1.12Billion
as of May 15, 2026First Light Asset Management, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that First Light Asset Management, LLC made a return of -8.57% in the last quarter. In trailing 12 months, it's portfolio return was 25.43%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| trisalus life sciences inc | 20,267,300 |
| tectonic therapeutics inc | 20,021,700 |
| omnicell inc | 16,351,100 |
| genedx holdings corp | 15,600,800 |
| spyglass pharma inc | 9,716,250 |
| vaxcyte inc | 8,239,070 |
| enliven therapeutics inc | 7,913,190 |
New stocks bought by First Light Asset Management, LLC
Additions
| Ticker | % Inc. |
|---|---|
| apogee therapeutics inc | 102 |
| neuropace inc | 82.29 |
| palvella therapeutics inc | 38.3 |
| simulations plus inc | 33.72 |
| 908 devices inc | 25.57 |
| tandem diabetes care inc | 20.67 |
| septerna inc | 18.05 |
| irhythm technologies | 9.26 |
Additions to existing portfolio by First Light Asset Management, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| rhythm pharmaceuticals inc | -70.53 |
| vera therapeutics inc | -63.91 |
| atricure inc | -37.94 |
| edgewise therapeutics inc | -36.34 |
| centessa pharmaceuticals limited | -31.5 |
| axogen inc | -23.51 |
| twist bioscience corporation | -22.96 |
| establishment labs holdings | -17.51 |
First Light Asset Management, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| disc medicine inc | -41,544,700 |
| dyne therapeutics inc | -3,036,320 |
| abivax sa-adr | -11,958,100 |
| madrigal pharmaceuticals inc | -38,918,400 |
| ishares russell 2000 growth etf | -245,488 |
First Light Asset Management, LLC got rid off the above stocks
Sector Distribution
First Light Asset Management, LLC has about 76.5% of it's holdings in Healthcare sector.
- Healthcare
- Others
| Sector | % |
|---|---|
| Healthcare | 76.5 |
| Others | 22.1 |
| 1.4 |
Market Cap. Distribution
First Light Asset Management, LLC has about 2.3% of it's portfolio invested in the large-cap and mega-cap stocks.
- SMALL-CAP
- MID-CAP
- UNALLOCATED
- MICRO-CAP
- LARGE-CAP
| Category | % |
|---|---|
| SMALL-CAP | 42.4 |
| MID-CAP | 24.2 |
| UNALLOCATED | 22.1 |
| MICRO-CAP | 9 |
| LARGE-CAP | 2.3 |
Stocks belong to which Index?
About 64.2% of the stocks held by First Light Asset Management, LLC either belong to S&P 500 or RUSSELL 2000 index.
- RUSSELL 2000
- Others
| Index | % |
|---|---|
| RUSSELL 2000 | 64.2 |
| Others | 35.8 |
First Light Asset Management, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of First Light Asset Management, LLC
First Light Asset Management, LLC has 35 stocks in it's portfolio. About 59.9% of the portfolio is in top 10 stocks. NEO proved to be the most loss making stock for the portfolio. CNTA was the most profitable stock for First Light Asset Management, LLC last quarter.
$1.12BTotal Value
40.00Positions
15 May, 2026Last Reported
| Expand | Holdingsorted ascending | % Portfolio | Shares Held | $ Value | % Change |
|---|---|---|---|---|---|
 Amylyx Pharmaceuticals Inc First Light Asset Management, LLC's holding in Amylyx Pharmaceuticals Inc over time | 3.97% | 3,190,640 | $44.35M 3.97% | 4.91%decreased 4.91 percentreduced | |
 Anaptys Bio Inc Anaptys Bio IncANAB First Light Asset Management, LLC's holding in Anaptys Bio Inc over time | 2.81% | 848,142 | $31.36M 2.81% | 12.5%decreased 12.5 percentreduced | |
 Atricure Inc Atricure IncATRC First Light Asset Management, LLC's holding in Atricure Inc over time | 1.86% | 729,521 | $20.81M 1.86% | 37.94%decreased 37.94 percentreduced | |
 Axogen Inc Axogen IncAXGN First Light Asset Management, LLC's holding in Axogen Inc over time | 11.88% | 4,002,770 | $132.61M 11.88% | 23.51%decreased 23.51 percentreduced | |
 Butterfly Network Inc First Light Asset Management, LLC's holding in Butterfly Network Inc over time | 0.96% | 2,660,170 | $10.75M 0.96% | 5.4%decreased 5.4 percentreduced | |
 Centessa Pharmaceuticals Limited First Light Asset Management, LLC's holding in Centessa Pharmaceuticals Limited over time | 5.56% | 1,560,990 | $62.00M 5.56% | 31.5%decreased 31.5 percentreduced | |
 Crinetics Pharmaceuticals Inc First Light Asset Management, LLC's holding in Crinetics Pharmaceuticals Inc over time | 3.55% | 1,089,670 | $39.58M 3.55% | 8.76%decreased 8.76 percentreduced | |
 Dyne Therapeutics Inc First Light Asset Management, LLC's holding in Dyne Therapeutics Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Establishment Labs Holdings First Light Asset Management, LLC's holding in Establishment Labs Holdings over time | 1.57% | 307,738 | $17.47M 1.57% | 17.51%decreased 17.51 percentreduced | |
 Edgewise Therapeutics Inc First Light Asset Management, LLC's holding in Edgewise Therapeutics Inc over time | 2.83% | 1,001,850 | $31.56M 2.83% | 36.34%decreased 36.34 percentreduced | |
 Guardant Health First Light Asset Management, LLC's holding in Guardant Health over time | 2.32% | 280,299 | $25.89M 2.32% | 4.9%decreased 4.9 percentreduced | |
 Health Catalyst Inc First Light Asset Management, LLC's holding in Health Catalyst Inc over time | 1.47% | 12,878,700 | $16.36M 1.47% | 0.25%decreased 0.25 percentreduced | |
 IJR Ishares Russell 2000 Growth EtfIshares Russell 2000 Growth EtfIJR | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Irhythm Technologies First Light Asset Management, LLC's holding in Irhythm Technologies over time | 1.78% | 168,116 | $19.84M 1.78% | 9.26%increased 9.26 percentadded | |
 Koru Medical Systems Inc First Light Asset Management, LLC's holding in Koru Medical Systems Inc over time | 1.46% | 3,768,380 | $16.28M 1.46% | 10.5%decreased 10.5 percentreduced | |
 908 Devices Inc 908 Devices IncMASS First Light Asset Management, LLC's holding in 908 Devices Inc over time | 3.33% | 6,072,560 | $37.16M 3.33% | 25.57%increased 25.57 percentadded | |
 Madrigal Pharmaceuticals Inc First Light Asset Management, LLC's holding in Madrigal Pharmaceuticals Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Mimedx Group Inc Mimedx Group IncMDXG First Light Asset Management, LLC's holding in Mimedx Group Inc over time | 1.01% | 2,842,890 | $11.23M 1.01% | 6.46%decreased 6.46 percentreduced | |
 Neogenomics Inc First Light Asset Management, LLC's holding in Neogenomics Inc over time | 6.47% | 9,729,980 | $72.20M 6.47% | 3.04%decreased 3.04 percentreduced | |
 Neuropace Inc Neuropace IncNPCE First Light Asset Management, LLC's holding in Neuropace Inc over time | 2.9% | 2,459,970 | $32.35M 2.9% | 82.29%increased 82.29 percentadded | |